About Us
Choose Us
- Our highly skilled and experienced team works single-mindedly to provide you with innovative new tools.
- Proteon Pharmaceuticals uses precision biology and the latest tools in the market to provide you with the best solutions.
- We join our hands with you, no matter where you are in your production cycle and use our expertise to help you meet your goals.
- Our products eliminate the unnecessary use of antibiotics, improve the quality of production & are eco-friendly.
Our Mission
Proteon Pharmaceuticals uses precision biology to modulate the microbiome to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.
We deliver natural, safe and environmentally sustainable products developed from our patented phage-platform technology.
Proteon Pharmaceuticals partners with farmers to provide solutions that improve the economic efficiency of farms, while promoting environmentally sound, natural and sustainable solutions.
Team
Prof. Jaroslaw Dastych, PhD
Founder & Chief Executive Officer
Prof. Jaroslaw Dastych
PhD Founder & Chief Executive Officer
Professor Jarosław Dastych is the Founder, CEO and President of the Board of Proteon Pharmaceuticals S.A., an innovative biotechnology company developing alternatives to antibiotics in animal, plant and human health. Prof. Dastych received his PhD in Medical Biology from the Medical University of Łódź in 1991 and started his scientific career at the Polish Academy of Sciences in Lodz, Poland. For several years he worked at the US National Institute of Health (NIH) in Bethesda, USA. In 2000 Prof. Dastych established the first research laboratory at the newly created International Institute of Molecular and Cell Biology in Warsaw. In 2005 Prof. Dastych established Proteon Pharmaceuticals. The company has developed a unique bacteriophage platform technology for development of effective alternatives to solving and preventing bacterial disease in animal farming and aquaculture as well as egg production and poultry farming. Its research platform and products have won international recognition and numerous innovation awards.
Prof. Dastych research interests range from immunology, toxicology and molecular biology to the development of novel diagnostic tools and bacteriophage-based or related treatment of disease. He has coordinated twelve European R&D projects. He is the author of over 40 publications in international scientific journals and has co-authored 4 biotechnology-related patents.
Bruno Maineult
Chief Transformation & Strategy Officer
Bruno Maineult is the Chief Transformation & Strategy Officer of Proteon Pharmaceuticals SA…
Bruno Maineult
Chief Transformation & Strategy Officer
Bruno Maineult is the Chief Transformation & Strategy Officer of Proteon Pharmaceuticals SA, as well as the Chief Executive Officer of its AI subsidiary, PhageAI SA. He has over 20 years of experience in management in Poland and Europe including his roles as Board Member of a German tech corporation controlled by Private Equity and Head of Financial Planning & Analysis of the Polish telecom incumbent.
Cross-cultural fluent and a Hi-tech enthusiast, Bruno has developed a solid experience in Biotech for the last 7 years now.
Beyond his work experience in companies of all sizes, he has built his entrepreneurial skills through participating in several innovative projects in education, multimedia and financial services as a Freelancer and as an Angel Investor in Poland.
Bruno is savvy about organization management and the impact of digitalization on individual and collective performance, including the strengthening of effective and synergetic cooperation between teams.
Jakub Korczak
Chief Financial Officer
Jakub is the Chief Financial Officer of Proteon Pharmaceuticals…
Jakub Korczak
Chief Financial Officer
Jakub is the Chief Financial Officer of Proteon Pharmaceuticals, overseeing comprehensive financial management and reporting, budgeting, long-term planning, and leading the company’s fundraising and capital markets initiatives.
With over 25 years of professional experience, he has held CFO and board member roles in both public and private companies across Europe and North America.
Jakub excels in managing capital markets activities, including conducting IPOs/SPOs, securing funding through equity and debt, and executing extensive M&A projects. Jakub holds a degree in Financial Management and Accounting from the University of Lodz (Poland) and he has further enhanced his expertise through the Advanced Management Program at IESE Business School in Barcelona (Spain).
Justyna Andrysiak
Chief Product Development Officer
Justyna Andrysiak
Chief Product Development Officer
Justyna is the Chief Product Development Officer of Proteon Pharmaceuticals where she is responsible for the acquisition of more than EUR 7.7mln in non-dilutive R&D and commercial grants. Justyna is an experienced project manager supporting multiple projects with high complexity and managing external grant acquisition, execution and compliance. Her dedication to building a culture based on bottoms-up initiatives and collaboration across organizational boundaries results in a true one team approach to innovation. She also provides day-to-day leadership and supervision of Administration, Human Resources, Real Estate, Procurement and Corporate Affairs.
Justyna holds a master’s degree in Biotechnology (specialization in Technical Biochemistry) and is a certified project manager.
Ewelina Wójcik, PhD
Chief Scientific Officer
Ewelina Wójcik, PhD
Chief Scientific Officer
Ewelina is the Chief Scientific Officer at Proteon Pharmaceuticals where she manages a +40-person R&D Function. A scientist in the fields of Microbiology and Molecular Genetics, wrote her Ph.D. thesis on “Unusual DNA structures as endogenous mutagens in mycobacteria”. She is responsible for the scientific development of bacteriophage products (BAFASAL, BAFADOR, anti-Avian Pathogenic E. coli product, anti-Mastitis product, anti-Campylobacter product).
Ewelina has recently volunteered to work in the Coronovirus Diagnostic Center in Łódź, Poland which was established to increase efficacy in testing SARS Cov-2.
Nipun Gupta
Chief Commercial Officer
Nipun Gupta
Chief Commercial Officer
Nipun is the Chief Commercial Officer of Proteon Pharmaceuticals where he is responsible for the company’s global sales, sales support, contract management, client services, distribution and marketing. He is an accomplished Senior Manager with +20 years’ experience of successfully developing new business and markets, with a passion for strategic commercial management and sales. Instrumental in defining the organization’s strategy; exemplary record in efficient delivery, with primary focus on achieving sales revenue targets and growth. Nipun possesses a determination to capitalize on international business exposure, broad cross-industry experience with leading multinational corporations and a developed, effective network of executive relations across Europe, Russia and the CIS region.
He is adept at identifying commercial opportunities, carrying out feasibility analysis, strategy development, go-to-market and business model development.
Arkadiusz Wojtasik, PhD
Production Director
Arkadiusz Wojtasik, PhD
Production Director
As the Production Director at Proteon Pharmaceuticals, Arkadiusz supervises the biotechnology team of Phage Products and Autovaccines Departments, where he has successfully built up a pilot-scale phage product manufacturing line from the foundation and he is currently developing full-scale production using breakthrough proprietary technology. Arkadiusz is qualified in optimization of phage-related bioprocess and scale-up operations and is a proficient, dedicated and quality-oriented manager who supports a dynamic, innovative and positive work environment. Co-developer of 4 novel products and the related exclusive know-how.
Małgorzata Stańczyk, PhD
Director of Regulatory Affairs
Małgorzata Stańczyk, PhD
Director of Regulatory Affairs
